A Phase 1 Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI188 in Advanced Malignancies
Clinical trial NCT03717103 · COMPLETED
Trial details
- NCT number
- NCT03717103
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-10
- Primary completion
- 2022-02-16
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.